ROSSI SEBASTIANO, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 608
EU - Europa 354
AS - Asia 221
AF - Africa 7
OC - Oceania 2
SA - Sud America 2
Totale 1.194
Nazione #
US - Stati Uniti d'America 599
IT - Italia 168
SG - Singapore 106
CN - Cina 61
DK - Danimarca 44
IE - Irlanda 39
SE - Svezia 26
DE - Germania 15
IN - India 13
ID - Indonesia 11
PL - Polonia 11
JP - Giappone 10
BE - Belgio 9
CA - Canada 9
GB - Regno Unito 9
ES - Italia 6
FR - Francia 6
KR - Corea 6
CH - Svizzera 5
NL - Olanda 4
UA - Ucraina 4
VN - Vietnam 4
FI - Finlandia 3
HK - Hong Kong 3
TW - Taiwan 3
AU - Australia 2
CL - Cile 2
DZ - Algeria 2
IR - Iran 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
LV - Lettonia 1
PT - Portogallo 1
RU - Federazione Russa 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 1.194
Città #
Santa Clara 120
Singapore 100
Chandler 70
Ann Arbor 56
Turin 41
Dublin 39
Torino 29
Columbus 18
Nyköping 16
Ashburn 14
Fairfield 14
Milan 14
Medford 13
Jakarta 11
Princeton 10
Houston 9
Munich 8
Brussels 7
Rome 7
Beijing 6
Guangzhou 6
Pune 6
Seattle 6
Woodbridge 6
Cumiana 5
Paris 5
Toronto 5
Warsaw 5
Amsterdam 4
Dearborn 4
Rho 4
Santa Cruz 4
Seoul 4
Washington 4
West Lafayette 4
Wilmington 4
Boardman 3
Boston 3
Brooklyn 3
Cambridge 3
Duncan 3
Fogliano Redipuglia 3
Fremont 3
Gdansk 3
Helsinki 3
Ichibachō 3
Kent 3
Krakow 3
Mundelein 3
New York 3
Parma 3
Taipei 3
Zurich 3
Abuja 2
Arlon 2
Asahikawa 2
Barcelona 2
Bend 2
Bengaluru 2
Bologna 2
Bronshoj 2
Chennai 2
Dong Ket 2
Genoa 2
Gorgonzola 2
Guidizzolo 2
Hebei 2
Hong Kong 2
Hwaseong-si 2
Indianapolis 2
Jijelli 2
Koenigs Wusterhausen 2
Kyoto 2
Los Angeles 2
Madrid 2
Magenta 2
Montreal 2
Nanjing 2
Nottingham 2
Novara 2
Pisa 2
San Antonio 2
San Diego 2
Sapporo 2
Snohomish 2
Stockholm 2
Uppsala 2
Andover 1
Bern 1
Bonn 1
Brisbane 1
Brno 1
Bungarribee 1
Calgary 1
Camerino 1
Cento 1
Central 1
Colleferro 1
Como 1
Coquimbo 1
Totale 810
Nome #
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. 248
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs beyond the Rule of 5 163
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin 96
Are we ready to design oral PROTACs®? 81
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) 78
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral Drugs 75
Dall’intelligenza artificiale nuove prospettive per la ricerca sulle malattie rare 73
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer 48
DNA methylation analysis in patients with neurodevelopmental disorders improves variant interpretation and reveals complexity 40
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression 39
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia 38
Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies 37
Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype 35
Designing Soluble PROTACs: Strategies and Preliminary Guidelines 35
Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader 32
Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot 28
Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5 28
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation Complexes 22
Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs 21
Preclinical alternative drug discovery programs for monogenic rare diseases. Should small molecules or gene therapy be used? The case of hereditary spastic paraplegias 12
Totale 1.229
Categoria #
all - tutte 4.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 0 8 11 16 10 9 9 10
2020/202147 3 1 2 1 0 2 1 3 6 5 4 19
2021/2022196 15 7 6 13 11 8 5 11 18 27 47 28
2022/2023286 20 20 16 26 15 69 32 14 32 7 21 14
2023/2024187 18 34 12 9 9 14 5 21 3 13 17 32
2024/2025409 11 60 37 64 173 64 0 0 0 0 0 0
Totale 1.229